Atrial Fibrillation Screening Program Cost-Effective in Elderly
WEDNESDAY, Nov. 16, 2022 (HealthDay News) -- A broad atrial fibrillation (AF) screening program is cost-effective in an elderly population, according to a study published online Nov. 9 in the European Heart Journal.
Johan Lyth, M.D., from Linköping University in Sweden, and colleagues estimated the cost-effectiveness of population-based screening for AF using clinical outcomes. The prevalence of AF, use of oral anticoagulation, clinical event data, and all-cause mortality were extracted from the STROKESTOP randomized study, involving 27,975 persons aged 75 or 76 years who were randomly assigned into a screening and control group.
The researchers found 77 life years gained and 65 quality-adjusted life years gained per 1,000 individuals invited to screening. In the screening invitation group, the incremental cost was €1.77 million lower. The gain in quality-adjusted life years at a lower cost indicated that the screening strategy was dominant. Based on the results from 10,000 Monte Carlo simulations, the AF screening strategy was cost-effective in 99.2 percent of the simulations and cost-saving in 92.7 percent. Screening of 1,000 individuals resulted in 10.6 fewer strokes, 1.0 more case of systemic embolism, and 2.9 fewer bleeds associated with hospitalization in the base-case scenario.
"The implication of this study is that population-based AF screening for 75/76-year-old individuals is cost-effective at a probability of 99.2 percent and cost-saving at a probability of 92.7 percent and should therefore be implemented," the authors write.
Several authors disclosed financial ties to the pharmaceutical industry.
Related Posts
Women With PCOS Face Twice the Odds for Ovarian Cancer After Menopause
TUESDAY, June 27, 2023 (HealthDay News) -- The risk for ovarian cancer among...
La tasa de vacunación contra el VPH de los niños de EE. UU. se ha estancado
JUEVES, 24 de agosto de 2023 (HealthDay News) -- Por primera vez en una década,...
Two Top Officials in FDA’s Vaccine Review Office to Retire
WEDNESDAY, Sept. 1, 2021 (HealthDay News) -- Two senior leaders in the U.S. Food...
Las dietas que reducen el hierro en el cerebro podrían conservar su agudeza
LUNES, 13 de septiembre de 2021 (HealthDay News) -- Los adultos mayores que...